Skip to content

Compounders Research Compare

Your trusted source for comprehensive financial data, stock research, and market analysis.

Quick Links

Login
Sign up
Stock Screener
Watchlist

Explore

Compounders
Compare Stocks
Stock Lists
Research
Highest Dividend Yield
Lowest P/E Ratio
Dividend Aristocrats

Company

About Us
Contact
Help Center

Join Our Community

Connect with fellow investors, share ideas, and get product updates in our Discord community.

Join our Discord

Important disclaimer

TGMCharts is a financial-data and research tool, not a broker-dealer, investment adviser, or financial planner, and nothing on this site is a recommendation or solicitation to buy, sell, or hold any security. Everything we publish is for general informational and educational purposes only and is not personalized investment, legal, or tax advice. Figures are sourced from third-party providers and our own calculations; while we work hard to keep them accurate and current, we do not warrant that any data, metric, chart, or analysis is complete, error-free, or up to date, and prices are not real-time. Past performance does not predict future results, and any decision you make using this site is your own responsibility. To the fullest extent permitted by law, TGM Ventures, Inc. and TGMCharts are not liable for any loss or damage arising from use of, or reliance on, anything on this site. Company names and logos are the property of their respective owners and appear for identification and editorial purposes only.

© 2026 TGM Charts. All rights reserved.

Terms Privacy Disclaimer

AstraZeneca PLC (AZN) Compounder Charts | TGMCharts

Home/Compounders/AZN

AstraZeneca PLC (AZN) compounder charts

Annual operating cash flow and quarterly year-over-year growth against the 30% line over the last 5 years — compounder charts by TGMCharts.

Metric

Revenue EPS Operating cash flow EBITDA Free cash flow

Growth bar

Window

Any stock

Operating cash flow · 5YDoes not currently clear the 15%+, 20%+, or 30%+ operating cash flow bars over 5Y.

AstraZeneca PLCAZN

Score: 17/100
5Y CAGR: 24.9%
Median YoY: 9.2%
YoY volatility: σ 34.1pp· choppy
Quarters ≥ 30%: 8 of 20
Negative quarters: 8
Valuation vs own 5Y history: P/OCF 21.3x · 5Y median 21.0x · 53rd percentile

Why this rank

Quarters at or above 30%: 8 of 20 → 16 of 40 pts
Steadiness (typical swing 34.1pp) → 0.6 of 25 pts
Pace (median 9.2% YoY) → 0 of 20 pts
Latest quarter (-9.5% YoY) → 0 of 15 pts
Score: 17 of 100

Annual operating cash flow · last 11 fiscal years

tgmcharts.com

Quarterly YoY operating cash flow growth vs the 30% line · 5Y

tgmcharts.com

P/OCF multiple vs its 5Y median · context only

tgmcharts.com

Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →